Early Life and Education
Christian Angermayer was born in Wiesau, Germany, on April 26, 1978. In 1998, he began studying biochemistry at the University of Bayreuth but later dropped out. During his time at university, he met professors who were working on RNA interference, which led him to co-found the biotech company Ribopharma AG in 2000.
Rise to Success
Angermayer's career took off with Ribopharma, which he co-founded at the age of 21. Although he held a minority stake, the company received backing from the German government. Ribopharma merged with Alnylam Pharmaceuticals in 2003. This venture made him a multimillionaire by the age of 25. He later founded Apeiron Investment Group, a family office and merchant banking business that invests in various sectors. Apeiron's portfolio includes stakes in public and private companies across the U.S., Germany, Canada, and Australia.
Key Business Strategies
Angermayer's business strategy revolves around identifying and investing in disruptive technologies and industries. Apeiron focuses on early-stage investments, and has expanded to include ventures in biotechnology, fintech, cryptocurrency, and longevity research. Angermayer often partners with well-known investors such as Peter Thiel and Michael Novogratz. He is known for his ability to network and connect people with capital and opportunities.
Philanthropy
Information on Angermayer's specific philanthropic activities is limited in the search results. However, he is a member of various organizations that promote social and economic development.